Items where authors include "Trudgill, N"

Export as [feed] Atom [feed] RSS
Jump to: Article
Number of items: 7.

Article

Gunn, D, Topan, R, Barnard, L orcid.org/0000-0001-5436-6882 et al. (19 more authors) (2023) Randomised, placebo-controlled trial and meta-analysis show benefit of ondansetron for irritable bowel syndrome with diarrhoea: The TRITON trial. Alimentary Pharmacology & Therapeutics, 57 (11). pp. 1258-1271. ISSN 0269-2813

Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736

Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736

Roberts, I, Shakur-Still, H, Afolabi, A et al. (511 more authors) (2020) Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT) : an international randomised, double-blind, placebo-controlled trial. Lancet, 395 (10241). pp. 1927-1936. ISSN 0140-6736

Gunn, D, Fried, R, Lalani, R et al. (22 more authors) (2019) Treatment of irritable bowel syndrome with diarrhoea using titrated ondansetron (TRITON): study protocol for a randomised controlled trial. Trials, 20. 517. ISSN 1745-6215

Palles, C, Chegwidden, L, Li, X et al. (95 more authors) (2015) Polymorphisms Near TBX5 and GDF7 Are Associated With Increased Risk for Barrett's Esophagus. Gastroenterology, 148 (2). pp. 367-378. ISSN 0016-5085

Palles, C, Chegwidden, L, Li, X et al. (95 more authors) (2015) Polymorphisms Near TBX5 and GDF7 Are Associated With Increased Risk for Barrett’s Esophagus. Gastroenterology, 148 (2). pp. 367-378. ISSN 0016-5085

This list was generated on Sun Mar 24 22:41:47 2024 GMT.